Modulation of cytotoxicity of chemotherapeutic drugs by activated H-γas
- 1 April 1997
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 53 (8) , 1203-1209
- https://doi.org/10.1016/s0006-2952(97)00101-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell lineBritish Journal of Cancer, 1995
- p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignanciesBlood, 1994
- P-glycoprotein, multidrug resistance and tumor progressionCancer and Metastasis Reviews, 1994
- p53-dependent apoptosis modulates the cytotoxicity of anticancer agentsCell, 1993
- Clinical and laboratory approaches to drug resistanceCurrent Opinion in Oncology, 1991
- Resistance to anticancer drugs in NIH3T3 cells transfected with c-myc and/or c-H-ras genesBritish Journal of Cancer, 1991
- Leucovorin rescue revisited.Journal of Clinical Oncology, 1990
- The ras Oncogenes Increase the Intrinsic Resistance of NIH 3T3 Cells to Ionizing RadiationScience, 1988
- High-efficiency transformation of mammalian cells by plasmid DNA.Molecular and Cellular Biology, 1987
- ras GENESAnnual Review of Biochemistry, 1987